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INTRODUCTION
Symposium on the pathogenetic mechanisms in nephritis
Scientific hypotheses are determined by the prejudices pre-
vailing when they are first formulated but molded by the
techniques available to test them. These phenomena are per-
fectly illustrated by the development of ideas of the pathogen-
esis of nephritis. The suggestion that nephritis was caused by
immunologically mediated injury is more than three quarters of
a century old, but could not be tested without ways to detect
immune reactants in glomeruli [1]. The first of these became
available late in the 1950s with the development of immunoflu-
orescent techniques able to detect tissue bound immunoglob-
ulins [2]. Within a short time, linear deposition of immunoglob-
ulins had been equated with antibodies binding to components
of the glomerular basement membrane (GBM), and granular
deposits, which were found in experimental models of serum
sickness, were presumed due to the deposition of immune
complexes from the circulation. Soon it became axiomatic that
there were two types of glomerular injury: the one autoimmune
and caused by anti-GBM antibodies and the other caused by
deposition of circulating immune complexes. At the time there
were no techniques for enumerating monocytes and lympho-
cytes in tissues and these were largely ignored, nor were
alternatives to deposited immune complexes often considered
as explanations for granular deposits.
Since then, the prevailing prejudices have changed to empha-
size that the importance of regulation of immunity is much more
apparent not only with regard to specific responses but also in
the way immune complexes are processed. Now there is almost
a surfeit of techniques to investigate immunologically mediated
disease as a result of advances made in molecular biology, cell
biology and immunochemistry. None of these developments of
the past ten years should obscure the real achievements of
earlier studies which clarified for the first time the relation
between immunopathology, inflammation and scarring (Fig. 1),
as well as possible genetic and environmental influences on
them. This was the major achievement of the early modern
period of research in nephritis. It has been very well reviewed
previously [3] and need not be further discussed here. The main
tasks for now are to define precisely the immunopathologies of
different types of clinical nephritis and to devise ways to
quantify their activity, to assess the state of activity of an
inflammatory response, and finally to understand the impetus to
glomerular and tubulointerstitial sclerosis. Needless to say the
completion of each of these tasks will provide substantial
opportunities for therapeutic intervention. The purpose of this
symposium on the Pathogenetic Mechanisms in Nephritis is to
review the progress that has been made in each of these areas.
The opening sections are concerned with various aspects of
autoimmunity which now seem likely to be more widely in-
volved in the pathogenesis of nephritis than previously realized.
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This follows the demonstration, first made in Heymann's ne-
phritis and subsequently in other systems, that antibodies to
cell surface antigens results in granular deposition of immuno-
globulin. The consequences of antibody binding to glomerular
epithelial and endothelial cells as well as to mesangial cells are
reviewed by Brentjens and Andres, and this is followed by a
discussion by Lockwood and Pusey of autoimmunity to glomer-
ular antigens that has been identified clinically. Obviously this
is just the beginning, and other recent examples of glomerular
autoimmunity occurring experimentally [4] as well as clinically
have been described [5]. Presently no one has reported an
autoantigen/antibody system in human membranous nephrop-
athy, but the search continues, not least because membranous
nephropathy satisfies one of the most important characteristics
of autoimmune disease, namely a strong association with spe-
cifi' major histocompatability class II antigens (HLA-DR3 in
Caucasoids and HLA-DR2 in Japanese). This and other aspects
of the generation of autoimmunity are discussed more generally
by Oliveira and Peters. They also point out two other attributes
of autoimmune disease: that autoimmune attack is usually
restricted to a small number of antigenic determinants (epi-
topes), and secondly that T lymphocytes are involved (i) by
providing T cell help to B cells, (ii) by secreting lymphokines
such as y-interferon capable of activating cells involved in
inflammation, and (iii) in some circumstances in the form of
cytotoxic T cells. This is especially pertinant as T cells have
been identified within glomeruli in some types of nephritis [6]
and more generally in interstitial infiltrates that invariably
accompany glomerulonephritis. The way in which T cell-medi-
ated immunity may be involved in autoimmune injury is exem-
plified by the experimental models of tubulointerstitial injury,
and these are reviewed by Wilson.
The next section is concerned with various aspects of inflam-
mation and injury. Up until five years ago it was believed that
the complement was important in glomerular injury exclusively
because the immune adherence reaction in which activated C3
increased the efficiency with which inflammatory cells bound to
fixed antibody. Heymann nephritis again provided the stimulus
for re-examining the role of complement, in particular that of
the membrane attack complex (MAC), as a cause of injury
independent of cells. This aspect of glomerular injury is re-
viewed here by Salant and his colleagues, who emphasize the
important contribution made through the use of monoclonal
antibodies able to detect a neo-antigen on the MAC complex.
Monoclonal antibodies have also been important in the studies
to define the role of endothelium in inflammation described by
Cotran and Pober. One of the most profound changes in
emphasis to have taken place recently in inflammation research
concerns the role of cytokines such as interleukin-l (IL-I) and
tumor necrosis factor (TNF) in regulating inflammation by
activating endothelium. These effects are likely to have great
importance in glomerular injury as infusions of small doses of
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Fig. 1. Relationship between immunopathology, inflammation, and
scarring, as well as genetic and environmental influences.
IL-i and TNF have already been shown to amplify injury
experimentally in nephritis [7] and because intrinsic glomerular
cells are capable of synthesizing cytokines [8]. Cytokines are
not the only substances involved in the regulation of glomerular
injury. Lianos reviewed the possible regulatory effects of eico-
sanoids, whose role is particularly tantalizing as they are also
involved in the physiological control of glomerular blood flow
and filtration. This highlights the potential influence that dif-
ferent physiological states (such as diet, or fluid and solute
excretion) might have on the intensity of glomerular inflamma-
tion.
The third section presents a re-examination of the role of
immune complexes. It is now realized that the generation of
immune complexes is a frequent occurrence in healthy individ-
uals and that powerful mechanisms, many involving comple-
ment, have evolved to prevent them from causing injury. These
are reviewed by Schifferli and Taylor together with ways in
which these defences may be overwhelmed or subverted.
D'Amico and his colleagues from Milan then describe cryoglob-
ulinemia which is the purest example of an immune complex
disease in man.
The most important reason for studying experimental models
of nephritis is to develop hypotheses to explain the pathogen-
esis of nephritis clinically. Ultimately such hypotheses have to
be tested in studies on patients, but before this is possible we
have to rely on analogies. Hoedemaeker and Weening discuss
these analogies critically and examine the inconsistencies be-
tween experimental models and clinical diseases. Lastly, Strom
and Kelly describe how increased understanding of the steps
involved in the development of an immune response can be
used to develop ways of more specific immunosuppression.
Their description of the immunosuppressive effects of a syn-
thetic IL-2/cholera toxin-specific molecule is a startling exam-
ple of the success of this approach; clearly it is just the first of
many such synthetic molecules.
At the start of this Introduction we suggested that scientific
hypotheses were determined by prevailing prejudices and
molded by the techniques available for testing them. Advances
in basic immunology over recent years have emphasized the
complexity and extraordinarily tight regulation of the immune
system by T lymphocytes. Against this background it seems
certain that T cells will be involved both directly and indirectly
in nephritis. The techniques are available to examine this
proposition critically in experimental models as well as clini-
cally. We hope that their role will be clarified in the next few
years.
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